Stevenage, United Kingdom

Simone Filosto

USPTO Granted Patents = 7 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Simone Filosto: Innovator in Antibody Development

Introduction

Simone Filosto is a prominent inventor based in Stevenage, GB, known for his significant contributions to the field of biomedicine. With a total of seven patents to his name, he specializes in the development of antibody agents that target human CD38, which are crucial in the fight against cancer. Filosto's work exemplifies the intersection of innovation and practicality, offering promising avenues for medical therapies.

Latest Patents

One of Filosto's noteworthy inventions is a series of patents focused on CD38 modulating antibody agents. These patents detail antibody sequences that bind effectively to human CD38, a protein that plays a vital role in various cellular functions. The disclosed sequences lead to the development of fully human antibodies, including monoclonal antibodies and their antigen-binding fragments, which are designed to be compatible with pharmaceutical manufacturing and process development. These advancements are particularly important for creating effective medical methods and compositions that can aid in cancer treatment.

Career Highlights

Simone Filosto is currently affiliated with Black Belt Therapeutics Limited, where he continues to innovate in antibody research and development. His impactful work not only contributes to the scientific community but also enhances therapeutic strategies available for combating serious health conditions like cancer. His dedication to research and development has established him as a valuable figure in his field.

Collaborations

Filosto collaborates closely with talented coworkers, such as Anne Goubier and Josephine Salimu. Their combined expertise fosters a creative environment that nurtures innovation while pushing the boundaries of medical research. Together, they are working to translate scientific discoveries into real-world applications that could transform treatment options for patients.

Conclusion

As an inventor, Simone Filosto is committed to advancing biomedical research through his innovative patent portfolio. His development of CD38 modulating antibody agents represents a promising frontier in cancer therapy. With strong partnerships and a focus on practical applications, Filosto's work is poised to make a lasting impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…